Article Versions Notes

Li Y, Jin Y, Taheri H, Schmidt KT, Gibson AA, Buck SAJ, Eisenmann ED, Mathijssen RHJ, Figg WD, Baker SD, et al. A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities. Pharmaceutics. 2022; 14(9):1933. https://doi.org/10.3390/pharmaceutics14091933

Li, Yang, Yan Jin, Hanieh Taheri, Keith T. Schmidt, Alice A. Gibson, Stefan A. J. Buck, Eric D. Eisenmann, Ron H. J. Mathijssen, William D. Figg, Sharyn D. Baker, and et al. 2022. "A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities" Pharmaceutics 14, no. 9: 1933. https://doi.org/10.3390/pharmaceutics14091933

Li, Y., Jin, Y., Taheri, H., Schmidt, K. T., Gibson, A. A., Buck, S. A. J., Eisenmann, E. D., Mathijssen, R. H. J., Figg, W. D., Baker, S. D., Sparreboom, A., & Hu, S. (2022). A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities. Pharmaceutics, 14(9), 1933. https://doi.org/10.3390/pharmaceutics14091933